Ignite Creation Date:
2024-07-17 @ 11:18 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06465316
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-06-17
Brief Title:
Testing Teclistamab TECVAYLI in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Sponsor:
Organization:
National Cancer Institute NCI